Aldosterone blockade in chronic kidney disease: can it improve outcome?

Current Opinion in Nephrology and Hypertension
Robert Toto

Abstract

The purpose of this review is to explain the rationale and limitations for use of mineralocorticoid receptor blockers (MRBs) for the treatment of chronic kidney disease (CKD) and its complications. Recent studies in animal models of CKD demonstrate that blockade of the mineralocorticoid receptor using spironolactone or eplerenone decreases inflammation, oxidative stress, proteinuria and glomerular and tubular injury. Patients with CKD are at very high risk for progression of kidney disease and major cardiovascular events. Recent studies in patients with CKD demonstrate that administration of low doses of MRBs added onto an angiotensin-converting enzyme inhibitor-based regimen reduces proteinuria--a risk marker for both progressive kidney disease and cardiovascular events. However, incident hyperkalemia, an unwanted side effect, dampened enthusiasm for this approach. There are no large-scale, long-term outcome trials examining whether MRB can slow progression of kidney disease or prevent cardiovascular events. At this time it is unknown whether mineralocorticoid receptor blockade can improve outcomes in patients with CKD. To move this field forward and determine whether these agents can improve the lives of patients with kidney ...Continue Reading

References

Apr 1, 1986·Australian and New Zealand Journal of Medicine·R D Gordon
Mar 23, 2000·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·R A RodbyE J Lewis
Sep 22, 2001·The New England Journal of Medicine·E J LewisUNKNOWN Collaborative Study Group
Sep 22, 2001·The New England Journal of Medicine·B M BrennerUNKNOWN RENAAL Study Investigators
Oct 5, 2002·Hypertension·Agostino VirdisErnesto L Schiffrin
Nov 21, 2002·JAMA : the Journal of the American Medical Association·Jackson T WrightUNKNOWN African American Study of Kidney Disease and Hypertension Study Group
Jan 31, 2003·The New England Journal of Medicine·Peter GaedeOluf Pedersen
Apr 2, 2003·The New England Journal of Medicine·Bertram PittUNKNOWN Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators
Dec 4, 2003·Molecular and Cellular Biology·Celine DelaloyXavier Jeunemaitre
Dec 19, 2003·The Journal of Biological Chemistry·Bing-E XuMelanie H Cobb
Jan 14, 2004·Hypertension·Theodore L GoodfriendKasem Nithipatikom
Jan 21, 2004·Hypertension·Theodore L Goodfriend, David A Calhoun
Aug 6, 2004·The New England Journal of Medicine·David N JuurlinkDonald A Redelmeier
May 11, 2005·The Journal of Biological Chemistry·Lisa Y LenertzMelanie H Cobb
Jan 24, 2006·Proceedings of the National Academy of Sciences of the United States of America·Ahmed LazrakChou-Long Huang
Mar 21, 2006·Clinical and Experimental Hypertension : CHE·Mohamed A BayorhDanita Eatman
May 20, 2006·Proceedings of the National Academy of Sciences of the United States of America·James B WadePaul A Welling
Jun 7, 2006·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Yu-Yan FanAkira Nishiyama
Oct 21, 2006·Journal of Hypertension·Anton H van den MeirackerFrans Boomsma
Dec 28, 2006·The Journal of Cell Biology·Anna ZagórskaDario R Alessi
Jan 3, 2007·American Journal of Hypertension·Justin Teiwes, Robert D Toto
Jan 4, 2007·Hypertension·Shigeru ShibataToshiro Fujita
Aug 19, 2007·Clinical Journal of the American Society of Nephrology : CJASN·Murray EpsteinBruce Beckerman
Oct 2, 2007·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Jun YuanYan Bao
Jan 4, 2008·Hypertension·Nancy J Brown
Jan 25, 2008·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Andrew S BombackPhilip J Klemmer
Feb 8, 2008·The New England Journal of Medicine·Peter GaedeOluf Pedersen
Feb 16, 2008·Current Opinion in Nephrology and Hypertension·Chou-Long HuangRobert D Toto
Feb 16, 2008·Current Opinion in Nephrology and Hypertension·Morag J Young
Mar 5, 2008·Clinical and Experimental Nephrology·Miki Nagase, Toshiro Fujita
Apr 2, 2008·The New England Journal of Medicine·UNKNOWN ONTARGET InvestigatorsCraig Anderson
Aug 7, 2008·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Young Sun KangDae Ryong Cha

❮ Previous
Next ❯

Citations

Dec 15, 2010·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Erin Elizabeth KellandGuido Filler
May 19, 2012·Clinical Journal of the American Society of Nephrology : CJASN·Pantelis A SarafidisKatie Vinen
Mar 13, 2014·BMC Nephrology·Anke HannemannHenri Wallaschofski
Dec 18, 2013·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Shahid Nadeem, Donald L Batisky
Apr 8, 2016·Nature Reviews. Cardiology·Gema Ruiz-HurtadoLuis M Ruilope
Mar 1, 2017·The Cochrane Database of Systematic Reviews·Tina Sc TamAaron M Tejani
Mar 9, 2019·Current Pharmaceutical Design·Vasilios G AthyrosAsterios Karagiannis
May 20, 2020·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Satoshi Morimoto, Atsuhiro Ichihara
Oct 19, 2016·Current Opinion in Nephrology and Hypertension·Omar Al Dhaybi, George Bakris
Dec 5, 2019·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Kerim Mutig, Sebastian Bachmann
Jul 17, 2021·Frontiers in Medicine·Isha SharmaYashpal S Kanwar
Nov 18, 2020·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Ramy M HannaKamyar Kalantar-Zadeh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Related Papers

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
Andrew S BombackPhilip J Klemmer
Clinical Journal of the American Society of Nephrology : CJASN
Gaurav JainDavid G Warnock
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Yaacov OriHertzel Salman
© 2021 Meta ULC. All rights reserved